Medimaps announces partnership with OsteoSys to bring Trabecular Bone Score to Korea’s leading bone densitometry platform
TBS Osteo™ is available on OsteoSys’s Primus Whole Body DXA, the company’s high-end DXA scanning product. The agreement expands worldwide access to Medimaps’ technology for clinicians across Southeast Asia, Europe, and South America. Financial terms were not disclosed.
Medimaps receives CE MDR certification for TBS Reveal, bringing opportunistic bone-fragility assessment to routine X-rays
TBS Reveal™ is designed to help shift bone care from reaction to prevention: To surface fragility risk before the first fracture, rather than diagnosing osteoporosis only after a break has occurred.
New Study in The Lancet’s eClinicalMedicine Demonstrates Strong Potential for Identifying Bone Fragility Risk from Routine X-Rays
Findings support the use of routine X-rays to help identify individuals at very high bone fragility risk who may benefit from further bone health evaluation.
Radiobotics to join Medimaps Group, creating a global provider of AI-driven musculoskeletal imaging software
Medimaps Group SA — the creator of TBS® (Trabecular Bone Score®), the global standard in bone microarchitecture assessment — and Radiobotics ApS, a leader in AI-powered musculoskeletal (MSK) radiology solutions, today announced that they have entered into a strategic merger agreement.
Medimaps collaborates with National Spine Health Foundation to advance AI-based bone fragility assessment in spine surgery
Medimaps announced a new clinical research partnership with the National Spine Health Foundation (NSHF), a nonprofit organization dedicated to patient education, research, and advocacy.
Medimaps launches TBS Osteo™ next-generation software in Europe for advanced bone microarchitecture assessment
Medimaps — the creator of TBS® (Trabecular Bone Score®), the global standard in bone microarchitecture assessment — today announced the European launch of its MDR-cleared, next-generation TBS Osteo™ Advanced software. Following the product’s launch in the United States the previous month, this milestone reflects the company’s commitment to advancing osteoporosis detection and bone health management worldwide.
Medimaps expands in the U.S. with the launch of TBS Osteo™ next-generation software for advanced bone microarchitecture assessment
Medimaps — the creator of TBS® (Trabecular Bone Score®), the global standard in bone microarchitecture assessment — is further expanding its presence in the US with the launch of its FDA-cleared next-generation TBS Osteo™ Advanced software. This milestone reflects the company’s commitment to advancing osteoporosis detection and bone health management in the US market with innovative solutions.
TBS included in national guidelines for diagnosis and treatment of osteoporosis in Slovakia
TBS® (Trabecular Bone Score®) has recently been included in the national guideline for the diagnosis and treatment of osteoporosis in Slovakia.
SimonMed Imaging integrates TBS Osteo into DXA scans across 80+ US locations
Medimaps announced that SimonMed Imaging has integrated TBS Osteo™ into its DXA scans, enhancing fracture risk assessment for patients across the US. This integration makes TBS® available to more people, supporting better bone health diagnostics.
Medimaps breaks new ground in fracture risk assessment with FDA clearance and MDR certification for TBS Osteo™ next-generation software
Medimaps announced 510(k) clearance from the FDA and MDR certification in the EU for the latest version of its flagship software, TBS Osteo™. This next-generation software is designed to enhance bone microarchitecture evaluation, broaden patient eligibility, and improve connectivity within medical facilities.